Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-11
1988-11-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61U 3152
Patent
active
047849991
ABSTRACT:
A method for the treatment of cerebral vascular and neuronal degenerative disorders associated with learning, memory and cognitive dysfunctions including cerebral senility, multi-infarct dementia and senile dementia of the Alzheimer type and/or peripheral vascular disease and/or proliferative skin disease in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4225607 (1980-09-01), Goring et al.
patent: 4454138 (1984-06-01), Goring
Angersbach Dieter
Arch Jonathan R. S.
Goring Joachim
Morgan Brian
Nicholson Charles D.
Beecham Wuelfing GmbH & Co. KG
Friedman Stanley J.
LandOfFree
Novel treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1103759